Raffaele Baffa

Raffaele Baffa

Company: Ziopharm Oncology

Job title: CMO

Seminars:

Break Out Audience Discussion 12:40 pm

How do we enhance receptor-target interactions to develop safe and efficacious TCR products? Overcoming T Cell exhaustion to enhance persistence in vivo Exploring gamma delta T cells as an avenue to circumvent safety concerns and maintain efficacy Investigating the action of gamma delta 1 receptor recognitionRead more

day: Focus Day

Genetic Engineering of T cells to Target Neoantigens in Solid Tumors 12:10 pm

Non-viral gene transfer such as the Sleeping Beauty system can be used to express neoantigen-specific TCRs T cells can be engineered to target public neoantigens shared between tumors and patients such as KRAS and TP53 T cells can be engineered to target private neoantigens unique to tumors and patientsRead more

day: Focus Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.